|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61K 31/444 | (2006.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/4725 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/5386 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| C07D 519/00 | (2006.01) |
| (11) | Number of the document | 3517538 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17853220.6 |
| Date of filing the European patent application | 2017-09-26 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (86) | Number | PCT/JP2017/034620 |
| Date | 2017-09-26 |
| (87) | Number | WO 2018/056453 |
| Date | 2018-03-29 |
| (30) | Number | Date | Country code |
| 2016187605 | 2016-09-26 | JP |
| (72) |
YOSHINO, Hitoshi , JP
TSUCHIYA, Satoshi , JP
MATSUO, Atsushi , JP
SATO, Tsutomu , JP
NISHIMOTO, Masahiro , JP
OGURI, Kyoko , JP
OGAWA, Hiroko , JP
NISHIMURA, Yoshikazu , JP
FURUTA, Yoshiyuki , JP
KASHIWAGI, Hirotaka , JP
HORI, Nobuyuki , JP
KAMON, Takuma , JP
SHIRAISHI, Takuya , JP
YOSHIDA, Shoshin , JP
KAWAI, Takahiro , JP
TANIDA, Satoshi , JP
AOKI, Masahide , JP
|
| (73) |
Chugai Seiyaku Kabushiki Kaisha ,
5-1, Ukima 5-chome, Kita-ku
Tokyo 115-8543,
JP
|
| (74) |
Jelena GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Pirazolpiridino darinys, pasižymintis GLP-1 receptoriaus agonisto poveikiu |
| PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 9 | 208.00 EUR |
| 2026-09-26 |